Literature DB >> 30770949

18F-FDG PET/CT in multiple myeloma: critical insights and future directions.

Clément Bailly1,2, Thomas Carlier1,2, Bastien Jamet2, Cyrille Touzeau1,3, Philippe Moreau1,3, Françoise Kraeber-Bodéré1,2,4, Caroline Bodet-Milin5,6.   

Abstract

Entities:  

Year:  2019        PMID： 30770949     DOI： 10.1007/s00259-019-04279-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  23 in total

1.  Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

Authors:  Cristina Nanni; Elena Zamagni; Annibale Versari; Stephane Chauvie; Andrea Bianchi; Marco Rensi; Marilena Bellò; Ilaria Rambaldi; Andrea Gallamini; Francesca Patriarca; Francesca Gay; Barbara Gamberi; Michele Cavo; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-16       Impact factor: 9.236

2.  Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.

Authors:  Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

3.  The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients.

Authors:  Cristina Nanni; Elena Zamagni; Monica Celli; Paola Caroli; Valentina Ambrosini; Paola Tacchetti; Annamaria Brioli; Beatrice Zannetti; Annalisa Pezzi; Lucia Pantani; Giulia Perrone; Maurizio Zompatori; Michele Cavo; Patrick M Colletti; Domenico Rubello; Stefano Fanti
Journal:  Clin Nucl Med       Date:  2013-02       Impact factor: 7.794

4.  PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.

Authors:  Elena Zamagni; Cristina Nanni; Katia Mancuso; Paola Tacchetti; Annalisa Pezzi; Lucia Pantani; Beatrice Zannetti; Ilaria Rambaldi; Annamaria Brioli; Serena Rocchi; Carolina Terragna; Marina Martello; Giulia Marzocchi; Enrica Borsi; Ilaria Rizzello; Stefano Fanti; Michele Cavo
Journal:  Clin Cancer Res       Date:  2015-06-15       Impact factor: 12.531

5.  Reproducibility of metabolic measurements in malignant tumors using FDG PET.

Authors:  W A Weber; S I Ziegler; R Thödtmann; A R Hanauske; M Schwaiger
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

6.  Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

Authors:  Elena Zamagni; Francesca Patriarca; Cristina Nanni; Beatrice Zannetti; Emanuela Englaro; Annalisa Pezzi; Paola Tacchetti; Silvia Buttignol; Giulia Perrone; Annamaria Brioli; Lucia Pantani; Carolina Terragna; Francesca Carobolante; Michele Baccarani; Renato Fanin; Stefano Fanti; Michele Cavo
Journal:  Blood       Date:  2011-09-06       Impact factor: 22.113

7.  Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

Authors:  Meletios A Dimopoulos; Jens Hillengass; Saad Usmani; Elena Zamagni; Suzanne Lentzsch; Faith E Davies; Noopur Raje; Orhan Sezer; Sonja Zweegman; Jatin Shah; Ashraf Badros; Kazuyuki Shimizu; Philippe Moreau; Chor-Sang Chim; Juan José Lahuerta; Jian Hou; Artur Jurczyszyn; Hartmut Goldschmidt; Pieter Sonneveld; Antonio Palumbo; Heinz Ludwig; Michele Cavo; Bart Barlogie; Kenneth Anderson; G David Roodman; S Vincent Rajkumar; Brian G M Durie; Evangelos Terpos
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

8.  F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Authors:  Twyla B Bartel; Jeff Haessler; Tracy L Y Brown; John D Shaughnessy; Frits van Rhee; Elias Anaissie; Terri Alpe; Edgardo Angtuaco; Ronald Walker; Joshua Epstein; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

Review 9.  Extramedullary multiple myeloma.

Authors:  Matthew Weinstock; Irene M Ghobrial
Journal:  Leuk Lymphoma       Date:  2012-12-31

Review 10.  State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET.

Authors:  Thomas Carlier; Clément Bailly
Journal:  Front Med (Lausanne)       Date:  2015-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.